1MA.MU
MACOM Technology Solutions Holdings Inc
MunichEUREQUITY
DELAYED
Last price
227.30
▼ 6.80 (2.90%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
226.20
Prev close
234.10
Day high
227.30
Day low
226.20
Volume
0
Market cap
—
P/E (TTM)
—
52W range
104.00 – 352.75
Day trading desk
Gap from prior close
-3.37%
Prior close 234.10
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
0.49%
226.20 – 227.30
Position in range
100%
Near session high
ATR (14D)
11.26
4.95% of price
Prior day high
234.10
PDH
Prior day low
234.10
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 1
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-14.48%
-13.1%
1M
-7.71%
-11.4%
3M
-32.76%
-35.9%
6M
+10.34%
-0.7%
YTD
+54.63%
+42.3%
1Y
+111.44%
+91.4%
3Y
+207.16%
+133.0%
5Y
+328.87%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 1MA.MU open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $967.26M | $729.58M | $648.41M | $675.17M | +32.6% |
| Operating revenue | $967.26M | $729.58M | $648.41M | $675.17M | +32.6% |
| Cost of revenue | $438.26M | $335.81M | $262.61M | $268.99M | +30.5% |
| Gross profit | $529.00M | $393.77M | $385.80M | $406.18M | +34.3% |
| Research & development | $244.47M | $182.16M | $148.54M | $148.23M | +34.2% |
| Selling, general & admin | $154.88M | $137.95M | $129.85M | $125.28M | +12.3% |
| Total operating expense | $399.35M | $320.11M | $278.40M | $273.51M | +24.8% |
| Operating income | $129.65M | $73.67M | $107.40M | $132.67M | +76.0% |
| Net interest income | $24.34M | $17.85M | $8.42M | -$4.30M | +36.3% |
| Pre-tax income | -$29.02M | $91.53M | $115.16M | $243.12M | -131.7% |
| Tax provision | $25.18M | $14.67M | $23.58M | -$196.84M | +71.7% |
| Net income | -$54.21M | $76.86M | $91.58M | $439.95M | -170.5% |
| Net income to common | -$54.21M | $76.86M | $91.58M | $439.95M | -170.5% |
| Basic EPS | -0.73 | 1.07 | 1.29 | 6.30 | -168.2% |
| Diluted EPS | -0.73 | 1.04 | 1.28 | 6.18 | -170.2% |
| EBIT | -$23.51M | $96.66M | $127.54M | $251.67M | -124.3% |
| EBITDA | $39.79M | $163.91M | $179.69M | $308.90M | -75.7% |
| Basic shares | 73.99M | 71.96M | 70.80M | 69.78M | +2.8% |
| Diluted shares | 73.99M | 73.58M | 71.50M | 71.17M | +0.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $112.14M | $146.81M | $173.95M | $119.95M | -23.6% |
| Cash & short-term investments | $785.98M | $581.89M | $514.53M | $586.53M | +35.1% |
| Accounts receivable | $148.65M | $105.70M | $91.25M | $101.55M | +40.6% |
| Inventory | $237.84M | $194.49M | $136.30M | $114.96M | +22.3% |
| Total current assets | $1.21B | $903.08M | $761.19M | $813.08M | +33.4% |
| Property, plant & equipment | $230.29M | $176.02M | $149.50M | $123.70M | +30.8% |
| Goodwill & intangibles | $414.88M | $408.29M | $390.39M | $362.67M | +1.6% |
| Total assets | $2.10B | $1.76B | $1.55B | $1.57B | +19.8% |
| Total current liabilities | $325.12M | $108.18M | $83.53M | $97.21M | +200.5% |
| Current debt | $160.95M | — | — | — | — |
| Long-term debt | $339.63M | $448.28M | $447.13M | $565.92M | -24.2% |
| Total debt | $537.99M | $487.78M | $487.33M | $600.43M | +10.3% |
| Total liabilities | $776.26M | $629.30M | $605.64M | $729.07M | +23.4% |
| Retained earnings | -$240.06M | -$185.85M | -$262.71M | -$354.29M | -29.2% |
| Shareholder equity | $1.33B | $1.13B | $947.60M | $842.75M | +17.8% |
| Working capital | $879.97M | $794.89M | $677.67M | $715.87M | +10.7% |
| Net tangible assets | $912.21M | $718.05M | $557.21M | $480.08M | +27.0% |
| Shares issued | 74.50M | 72.22M | 71.01M | 70.02M | +3.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$54.21M | $76.86M | $91.58M | $439.95M | -170.5% |
| Depreciation & amortisation | $63.30M | $67.25M | $52.15M | $57.23M | -5.9% |
| Stock-based compensation | $79.36M | $45.64M | $38.10M | $41.19M | +73.9% |
| Change in working capital | -$37.79M | -$31.03M | -$27.77M | -$46.69M | -21.8% |
| Operating cash flow | $235.37M | $162.64M | $166.92M | $176.98M | +44.7% |
| Capital expenditure | -$82.17M | -$25.63M | -$24.70M | -$26.51M | -220.6% |
| Investing cash flow | -$328.26M | -$181.13M | $36.34M | -$182.86M | -81.2% |
| Share buybacks | -$43.13M | -$14.22M | -$32.62M | -$36.00M | -203.4% |
| Financing cash flow | $58.10M | -$9.06M | -$149.02M | -$28.91M | +741.0% |
| Free cash flow | $153.20M | $137.01M | $142.22M | $150.47M | +11.8% |
| End cash position | $112.14M | $146.81M | $173.95M | $119.95M | -23.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $342.24M | $288.95M | $271.61M | $261.17M | $252.08M | — | +18.4% |
| Operating revenue | $342.24M | $288.95M | $271.61M | $261.17M | $252.08M | — | +18.4% |
| Cost of revenue | $142.69M | $124.52M | $119.83M | $118.87M | $112.64M | — | +14.6% |
| Gross profit | $199.55M | $164.43M | $151.78M | $142.30M | $139.44M | — | +21.4% |
| Research & development | $74.31M | $68.98M | $66.46M | $62.88M | $63.38M | — | +7.7% |
| Selling, general & admin | $48.13M | $44.62M | $42.02M | $39.83M | $38.40M | — | +7.9% |
| Total operating expense | $122.44M | $113.60M | $108.48M | $102.71M | $101.78M | — | +7.8% |
| Operating income | $77.11M | $50.83M | $43.30M | $39.59M | $37.66M | — | +51.7% |
| Net interest income | $5.19M | $6.09M | $6.29M | $6.22M | $6.42M | — | -14.8% |
| Pre-tax income | $123.85M | $56.92M | $49.59M | $55.90M | $44.08M | — | +117.6% |
| Tax provision | $23.14M | $10.59M | $822.00K | $10.78M | $7.55M | — | +118.5% |
| Net income | $100.71M | $46.33M | $48.77M | $45.12M | $36.53M | — | +117.4% |
| Net income to common | $100.71M | $46.33M | $48.77M | $45.12M | $36.53M | — | +117.4% |
| Basic EPS | 1.32 | 0.62 | 0.65 | — | 0.49 | 0.43 | +112.9% |
| Diluted EPS | 1.28 | 0.60 | 0.64 | — | 0.48 | 0.42 | +113.3% |
| EBIT | $125.33M | $58.59M | $51.29M | $57.70M | $45.26M | — | +113.9% |
| EBITDA | $140.99M | $74.23M | $66.67M | $75.34M | $60.10M | — | +89.9% |
| Basic shares | 76.33M | 75.28M | 74.82M | — | 74.43M | 74.36M | +1.4% |
| Diluted shares | 78.41M | 77.56M | 76.72M | — | 75.86M | 75.74M | +1.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $89.60M | $98.52M | $119.65M | $112.14M | $125.47M | — | -9.1% |
| Cash & short-term investments | $663.03M | $664.86M | $768.49M | $785.98M | $735.23M | — | -0.3% |
| Accounts receivable | $179.15M | $159.60M | $160.06M | $148.65M | $129.49M | — | +12.2% |
| Inventory | $281.52M | $252.19M | $238.91M | $237.84M | $215.39M | — | +11.6% |
| Total current assets | $1.17B | $1.13B | $1.21B | $1.21B | $1.13B | — | +4.1% |
| Property, plant & equipment | $246.31M | $234.96M | $234.71M | $230.29M | $208.99M | — | +4.8% |
| Goodwill & intangibles | $396.96M | $402.99M | $408.54M | $414.88M | $411.82M | — | -1.5% |
| Total assets | $2.15B | $2.01B | $2.11B | $2.10B | $2.00B | — | +6.6% |
| Total current liabilities | $501.51M | $149.70M | $304.54M | $325.12M | $294.65M | — | +235.0% |
| Current debt | $340.46M | — | $160.56M | $160.95M | $160.84M | $160.74M | — |
| Long-term debt | — | $340.19M | $339.91M | $339.63M | $339.35M | $339.07M | — |
| Total debt | $377.49M | $377.31M | $531.45M | $537.99M | $531.55M | — | +0.0% |
| Total liabilities | $605.99M | $596.82M | $752.41M | $776.26M | $739.92M | — | +1.5% |
| Retained earnings | -$44.25M | -$144.96M | -$191.29M | -$240.06M | -$285.18M | — | +69.5% |
| Shareholder equity | $1.54B | $1.42B | $1.35B | $1.33B | $1.26B | — | +8.7% |
| Working capital | $670.77M | $976.35M | $901.47M | $879.97M | $832.71M | — | -31.3% |
| Net tangible assets | $1.14B | $1.01B | $944.58M | $912.21M | $851.53M | — | +12.7% |
| Shares issued | 76.39M | 76.32M | 75.03M | 74.50M | 74.49M | — | +0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $100.71M | $46.33M | $48.77M | $45.12M | $36.53M | +117.4% |
| Depreciation & amortisation | $15.65M | $15.64M | $15.38M | $17.65M | $14.85M | +0.1% |
| Stock-based compensation | $21.10M | $22.64M | $22.14M | $17.77M | $17.31M | -6.8% |
| Change in working capital | -$35.55M | -$11.29M | -$42.70M | -$3.53M | -$12.38M | -214.8% |
| Operating cash flow | $79.96M | $78.66M | $42.92M | $69.64M | $60.39M | +1.6% |
| Capital expenditure | -$82.79M | -$16.28M | -$17.26M | -$31.09M | -$38.63M | -408.4% |
| Investing cash flow | -$89.96M | $64.75M | $8.77M | -$82.13M | -$79.00M | -238.9% |
| Share buybacks | — | — | — | -$451.00K | — | — |
| Financing cash flow | $1.21M | -$164.50M | -$44.20M | -$697.00K | $32.51M | +100.7% |
| Free cash flow | -$2.83M | $62.38M | $25.66M | $38.55M | $21.76M | -104.5% |
| End cash position | $89.60M | $98.52M | $119.65M | $112.14M | $125.47M | -9.1% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
259.34
-12.36% from price
SMA 20
244.16
-6.91% from price
SMA 50
272.64
-16.63% from price
SMA 100
274.49
-17.19% from price
SMA 200
224.38
+1.30% from price
EMA 12
250.80
-9.37% from price
EMA 26
254.01
-10.52% from price
EMA 50
262.09
-13.27% from price
RSI (14)
40.4
Neutral
MACD (12,26,9)
-3.21
Hist 0.25
ATR (14)
11.26
4.95% of price
Realised vol 30D
83.8%
Annualised
Bollinger upper
288.81
20, 2σ
Bollinger lower
199.51
20, 2σ
50 / 200 cross
Golden
272.64 vs 224.38
Trend bias
Above 200
+1.30%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.42
Less volatile than market
Correlation to SPY
0.09
Largely independent
Realised vol 30D
83.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-42.7%
Peak to trough
Max drawdown 5Y
-44.0%
Peak to trough
ATR 14
11.26
4.95% of price
Beta (reported)
—
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 21, 26 | BMO Capital | INITIATED | — | Market Perform |
| Aug 7, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Aug 6, 26 | Needham | MAINTAINED | Buy | Buy |
| Jul 21, 26 | Susquehanna | MAINTAINED | Neutral | Neutral |
| Jun 24, 26 | Stifel | MAINTAINED | Buy | Buy |
| May 22, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| May 8, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| May 8, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| May 8, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| May 8, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| May 8, 26 | Susquehanna | MAINTAINED | Neutral | Neutral |
| May 8, 26 | Needham | MAINTAINED | Buy | Buy |
Headlines
147 Laps Around the Mall: Washington Hosts Freedom 250 Street Race
The Wall Street Journal · 10m ago
After Buying Circle Through a 42% Drop, Cathie Wood Says Analysts Cannot Fathom It
BeInCrypto · 10m ago
BC-Nikkei 225 Futures
Associated Press · 10m ago
Hugging Face exploring sale valuing it at $13 billion, Business Insider says
Reuters · 10m ago
Gilead’s Revenue Is Accelerating, But are its Acquisitions Worth the Cost?
Insider Monkey · 13m ago
Pfizer vs. Gilead: Which Drugmaker Has the Stronger Growth Story?
Insider Monkey · 16m ago
The Committee for a Responsible Federal Budget Estimates Social Security Cuts for Couples if the System Is Not Fixed
Motley Fool · 21m ago
Zoetis Earnings Reveal a Divided Business, But Can its Pipeline Restore Growth?
Insider Monkey · 21m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.